Related references
Note: Only part of the references are listed.Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study)
Janet Athene Lane et al.
BJU INTERNATIONAL (2022)
β3 Relaxant Effect in Human Bladder Involves Cystathionine γ-Lyase-Derived Urothelial Hydrogen Sulfide
Emma Mitidieri et al.
ANTIOXIDANTS (2022)
Vibegron for the treatment of overactive bladder: a comprehensive update
Stephanie Gleicher et al.
EXPERT OPINION ON PHARMACOTHERAPY (2022)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
The cognitive effect of anticholinergics for patients with overactive bladder
Blayne Welk et al.
NATURE REVIEWS UROLOGY (2021)
Mirabegron escalation to 50 mg further improves daily urgency and urgency urinary incontinence in Asian patients with overactive bladder
Chun-Hou Liao et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2019)
Incontinence after Prostate Treatment: AUA/SUFU Guideline
Jaspreet S. Sandhu et al.
JOURNAL OF UROLOGY (2019)
EAU Guidelines on Assessment and Nonsurgical Management of Urinary Incontinence
Arjun K. Nambiar et al.
EUROPEAN UROLOGY (2018)
De novo overactive bladder after robot-assisted laparoscopic radical prostatectomy
Yoshihisa Matsukawa et al.
NEUROUROLOGY AND URODYNAMICS (2018)
Pretransplant defunctionalized bladderoverrated condition?
Joao F. Neves Neto et al.
NEUROUROLOGY AND URODYNAMICS (2018)
Sex differences in lower urinary tract biology and physiology
Benjamin Abelson et al.
BIOLOGY OF SEX DIFFERENCES (2018)
Management of Overactive Bladder Symptoms After Radical Prostatectomy
Benoit Peyronnet et al.
CURRENT UROLOGY REPORTS (2018)
Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic Review
Michael Lardas et al.
EUROPEAN UROLOGY (2017)
Efficacy of solifenacin in the prevention of short-term complications after laparoscopic radical prostatectomy
Ranxing Yang et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2017)
Effect of preoperative urodynamic detrusor overactivity on post-prostatectomy incontinence: a systematic review and meta-analysis
Myong Kim et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2016)
Urodynamic Efficacy and Safety of Mirabegron Add-on Treatment with Tamsulosin for Japanese Male Patients with Overactive Bladder
Naoki Wada et al.
LUTS-LOWER URINARY TRACT SYMPTOMS (2016)
Prostate cancer changes in clinical presentation and treatments in two decades: an Italian population-based study
Annalisa Trama et al.
EUROPEAN JOURNAL OF CANCER (2016)
Multicenter Analysis of Urinary Urgency and Urge Incontinence in Patients with Anterior Urethral Stricture Disease before and after Urethroplasty
Lindsay A. Hampson et al.
JOURNAL OF UROLOGY (2016)
Urethroplasty Improves Overactive Bladder Symptoms in Men With Anterior Urethral Strictures
E. Charles Osterberg et al.
UROLOGY (2016)
Management of the incontinent patient with a sphincteric stricture following radical prostatectomy
Ashley Cox et al.
CURRENT OPINION IN UROLOGY (2014)
Safety and tolerability of the β3-adrenoceptor agonist mirabegron, for the treatment of overactive bladder: results of a prospective pooled analysis of three 12-week randomised Phase III trials and of a 1-year randomised Phase III trial
V. W. Nitti et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2014)
Pathophysiology of idiopathic overactive bladder and the success of treatment: A systematic review from ICI-RS 2013
Ann T. Hanna-Mitchell et al.
NEUROUROLOGY AND URODYNAMICS (2014)
Mirabegron: A Review of Its Use in Patients with Overactive Bladder Syndrome
Mark Sanford
DRUGS (2013)
The novel β3-adrenoceptor agonist mirabegron reduces carbachol-induced contractile activity in detrusor tissue from patients with bladder outflow obstruction with or without detrusor overactivity
Julie Svalo et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Mirabegron as a New Class of Oral Drug for Overactive Bladder Syndrome: Many Positive Perspectives, Some Concerns
Giacomo Novara et al.
EUROPEAN UROLOGY (2013)
Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies
V. W. Nitti et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2013)
β3-Adrenoceptor agonist mirabegron is effective for overactive bladder that is unresponsive to antimuscarinic treatment or is related to benign prostatic hyperplasia in men
Hideo Otsuki et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2013)
Efficacy of an assisted low-intensity programme of perioperative pelvic floor muscle training in improving the recovery of continence after radical prostatectomy: a randomized controlled trial
Daniele Tienforti et al.
BJU INTERNATIONAL (2012)
Modulation of non-voiding activity by the muscarinergic antagonist tolterodine and the β3-adrenoceptor agonist mirabegron in conscious rats with partial outflow obstruction
James I. Gillespie et al.
BJU INTERNATIONAL (2012)
Proarrhythmic Safety of Repeat Doses of Mirabegron in Healthy Subjects: A Randomized, Double-Blind, Placebo-, and Active-Controlled Thorough QT Study
M. Malik et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Pharmacokinetic Properties of Mirabegron, a β3-Adrenoceptor Agonist: Results From Two Phase I, Randomized, Multiple-Dose Studies in Healthy Young and Elderly Men and Women
Walter Krauwinkel et al.
CLINICAL THERAPEUTICS (2012)
Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline
E. Ann Gormley et al.
JOURNAL OF UROLOGY (2012)
Detrusor overactivity: an overview
Kiran Ashok et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2010)
The physiological function of lower urinary tract smooth muscle
C. H. Fry et al.
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL (2010)
Temporal Trends in Adoption of and Indications for the Artificial Urinary Sphincter
Richard Lee et al.
JOURNAL OF UROLOGY (2009)
Urodynamic Testing in Evaluation of Postradical Prostatectomy Incontinence Before Artificial Urinary Sphincter Implantation
H. Henry Lai et al.
UROLOGY (2009)
Bladder and urethral sphincter function after radical retropubic prostatectomy: A prospective long-term study
Antonella Giannantoni et al.
EUROPEAN UROLOGY (2008)
α1-, α2- and β-adrenoceptors in the urinary bladder, urethra and prostate
MC Michel et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Share Paper
